CareDx, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from CareDx, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
2.8×Over the last 3 years its own operating cash covered its investment spending (capex) 2.8 times.
Higher than 78% of Healthcare companies in United States.
Cash Locked Ratio
$16For every $100 of sales, $16 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $23 tied up three years earlier.
Less money tied up than 68% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
$95Sales grew 18% in 3 years; of every extra $100 of sales, $95 became extra profit.
Higher than 80% of Healthcare companies in United States.
Asset Productivity Ratio
+18% / -24%In 3 years sales changed by +18% while total assets changed by -24%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
6.5×Debt due within a year is covered 6.5 times by its yearly operating cash.
Higher than 82% of Healthcare companies in United States.
Cash Cushion Ratio
+4%Cash, after subtracting all debt, equals 4% of its market value (net cash).
Lower than 58% of Healthcare companies in United States.
Tangible Assets Ratio
83%Of every $100 the company owns, $83 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 53% of Healthcare companies in United States.
Tangible Net Worth Ratio
76%Of every $100 of net worth, $76 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 59% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
CareDx, Inc. owes $0.20 for every $1 it owns. CareDx, Inc. made a loss in the year to Dec 2025, after a profit the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
33.2Investors pay $33.2 for every $1 of CareDx, Inc.'s yearly profit, higher than 61% of Healthcare companies in United States.
P/B ratio
8.41The share price is 8.41 times CareDx, Inc.'s book value per share, higher than 84% of Healthcare companies in United States.
Market cap
$3.6 BThe total market value of all of CareDx, Inc.'s shares at today's price (share price × number of shares), larger than 81% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$426 MWhat CareDx, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$8.23Net worth divided by the number of shares. The share price of $69.16 is 8.4 times this, which is the P/B above.
Return on equity (ROE)
29.5%CareDx, Inc. earned 29.5% on its shareholders' money over the last year, higher than 93% of Healthcare companies in United States.
Owes vs Owns
0.20×CareDx, Inc. owes $0.20 for every $1 it owns (low), lower than 72% of Healthcare companies in United States.
Dividend yield
NoneCareDx, Inc. does not currently pay a dividend.
Revenue growth
+14%Revenue rose 14% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Profit growth
LossCareDx, Inc. made a loss in the year to Dec 2025, after a profit the year before.
Profit margin
-5.6%CareDx, Inc. lost $6 for every $100 of revenue.
Cash vs debt
Net cashCareDx, Inc. held $151 M more cash than debt (net cash) at Dec 2025.
Questions
What is CareDx, Inc.'s P/E ratio?
Investors pay $33.2 for every $1 of CareDx, Inc.'s yearly profit, higher than 61% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For CareDx, Inc.: $3.6 B ÷ $426 M (30 Jun 2026) = 8.4.
What is CareDx, Inc.'s return on equity?
CareDx, Inc. earned 29.5% on its shareholders' money over the last year, higher than 93% of Healthcare companies in United States.
How much does CareDx, Inc. owe compared with what it owns?
CareDx, Inc. owes $0.20 for every $1 it owns (low), lower than 72% of Healthcare companies in United States.
Does CareDx, Inc. pay a dividend?
No. CareDx, Inc. does not currently pay a dividend.
Is CareDx, Inc.'s revenue growing?
Revenue rose 14% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.